Skip to main content

Bank of Korea

13F filer · CIK 0001965704
Reported Aug 12, 2026
Net buyer this quarter
13F portfolio value$3.89BU.S. long equity reported on 13F
Positions21 new · 0 closed
Net flow last quarter+$6.11MBuys minus sells
Top 10 positions weight32.2%Concentration

Holdings

13F · last 4 quarters free
Scroll for earlier quarters
CompanyValue% of portfolio% of companyPOSITION CHANGE qoq %First reported
Q2 2026Reported Aug 12, 20262 positions
IDEVEndo Pharmaceuticals Solutions Inc.$1B25.79%Not reported-19.6%Q4 2025
GLDSPDR Gold Trust$250M6.44%0.19%NewQ2 2026
Q1 2026Reported May 14, 20261 positions
IDEVEndo Pharmaceuticals Solutions Inc.$1.17B28.31%Not reported+84.1%Q4 2025
Q4 2025Reported Feb 11, 20261 positions
IDEVEndo Pharmaceuticals Solutions Inc.$628M27.48%Not reportedNewQ4 2025
Premium opens every quarter this fund has filed
SpoorBase

Not investment advice. We make every effort to keep the information on SpoorBase accurate, but errors may occur. SpoorBase does not guarantee the accuracy or completeness of any data, and any use of the information is at the user’s sole responsibility. Valuation multiples are calculated by SpoorBase and may contain errors. See Disclosures. © 2026 SpoorBase. All rights reserved.